Over the past decade, a remarkable number of independent community gastroenterologists became part of larger groups, primarily due to financial concerns. Although the number of gastroenterologists increased between 2012 and 2020, the number of associated practices decreased by more than 650 (14%), with the number of physicians practicing in groups of less than 10 decreasing by nearly 1500 (35%).1 Simultaneously, the number of self-employed physicians decreased,2 while the number of hospital-employed and private equity affiliated physicians increased.3,4 Surveys of practices engaged in such consolidative behavior most often cite financial uncertainty given increased costs, decreased revenues, and continuing regulatory pressures, along…
Author: Abhay Panchal
As administrative burden and payer friction push more physicians toward burnout, a growing number are choosing a fundamentally different path — one that removes insurers from the equation entirely. Direct primary care, long associated with family medicine, is gaining traction as a model that specialists are increasingly watching and adapting. Dr. Vasanth Kainkaryam’s practice in Connecticut offers a concrete example: a subscription-based model where patients pay a flat monthly fee for comprehensive access, and the physician controls the pace, scope, and philosophy of care.
The administrative weight on physician practices is not just heavy — it is getting heavier, and Medicare Advantage is at the center of it. A new MGMA survey of over 230 group practices found that 95% reported an increase in regulatory burden over the past three years, with prior authorization, MA denials, and automatic downcoding ranking among the top pain points. The numbers behind the burden are striking: 40% of practices now employ three or more full-time administrative staff per physician just to manage regulatory requirements — a resource allocation that speaks to how deeply these demands have restructured the…
As independent practices buckle under rising costs, administrative burdens, and stagnant reimbursement, a new and unlikely cast of acquirers has entered the game, moving beyond the traditional hospital and health system playbook to stake claims across primary care and specialty medicine. From insurers to pharmaceutical companies, here’s who is reshaping the physician acquisition landscape.
The gastroenterology workforce shortage is not a new story, but it is an accelerating one. Nearly 50 million Americans live more than 25 miles from a gastroenterologist, and the forces driving that gap — pandemic-era early retirements, rising colorectal cancer screening demand, and growing administrative burden from private equity-driven practice models — show no signs of reversing. The result is a specialty where demand is structurally outpacing supply, and the pressure is landing squarely on the physicians who remain.
A University of Manchester research team has secured nearly £1 million in funding to develop snail-inspired soft robots capable of navigating the gastrointestinal tract and delivering cancer drugs directly to colorectal tumor sites. The concept draws from gastropod locomotion — slow, precise, and substrate-independent — to engineer miniature biocompatible robots that can be remotely guided through the gut via external magnetic fields, releasing their therapeutic payload only at the target site. The clinical problem the project is solving is real and persistent: protein kinase inhibitors, a class of drugs with strong potential against colorectal cancer, are currently limited by poor…
Researchers at the University of Geneva have built something the GI field has long been working toward: a stool-based colorectal cancer screening test powered by machine learning that detected 90% of cancer cases — approaching colonoscopy’s 94% detection rate and outperforming every existing non-invasive method. The key innovation wasn’t the use of gut bacteria per se, but the level of precision applied. Rather than analyzing broad bacterial species, the team mapped microbiota at the subspecies level — an intermediate resolution specific enough to capture disease-relevant differences, yet consistent enough to hold across diverse populations.
For decades, CBT for IBS has been treated as a psychological add-on — something referred when medications fall short. That framing is now being firmly corrected. With ACG guidelines recommending it as an early-line option and insurers increasingly recognizing it as a frontline treatment, CBT is gaining the clinical standing it has long deserved. The mechanism is biological as much as behavioral: CBT recalibrates brain-gut signaling, and research has demonstrated measurable changes in limbic activity, gut microbial composition, and symptom outcomes — including 61% of patients in a landmark RCT reporting meaningful improvement after just four home-based sessions.
A new AGA clinical practice update is pushing endoscopists to think beyond generator dials. While electrosurgical units (ESUs) are a staple of therapeutic GI endoscopy, the update makes clear that outcomes are shaped by the interplay of device settings, operator technique, tissue composition, and procedural environment — not any single factor in isolation. Notably, the evidence shows no meaningful difference in major outcomes between cut-predominant and coagulation-predominant currents for colorectal polypectomy, shifting the focus toward individualized, real-time decision-making rather than protocol-driven defaults. The update also elevates two practical priorities: hot snare remains the preferred approach for large pedunculated polyps due…
A Maricopa County jury sided with a gastroenterologist accused of failing to diagnose a fatal bowel obstruction, declining a $26.6 million damages claim brought by the family of Johnny Ballard, who died in 2019. The case centered on a critical clinical decision: whether a CT scan with contrast dye should have been ordered when Ballard presented with severe abdominal pain, rather than the non-contrast scan that was performed. The defense prevailed by establishing that Ballard’s condition — a volvulus, a rare post-gastric-bypass complication — is exceptionally difficult to detect without the clarity of hindsight. Dr. Chadha’s team argued that the…